Patents by Inventor Amanda Thomas

Amanda Thomas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11949527
    Abstract: Methods and systems are disclosed for performing operations for providing a shared augmented reality experience in a video chat. A video chat can be established between a plurality of client devices. During the video chat, videos of users associated with the client devices can be displayed. During the video chat, a request from a first client device to activate a first AR experience can be received, and in response, and body parts of users depicted in the videos are modified to include one or more AR elements associated with the first AR experience.
    Type: Grant
    Filed: April 25, 2022
    Date of Patent: April 2, 2024
    Assignee: SNAP INC.
    Inventors: Nathan Richard Banks, Nathan Kenneth Boyd, Amanda Durham, Alex Edelsburg, Maxim Maximov Lazarov, Ryan Thomas
  • Publication number: 20240101533
    Abstract: The present disclosure relates to methods and intermediates useful for preparing a compound of formula I: or a co-crystal, solvate, salt or combination thereof.
    Type: Application
    Filed: June 5, 2023
    Publication date: March 28, 2024
    Inventors: Kevin McCormack Allan, Amanda Lynn Vandehey, Gediminas Brizgys, Sachin Dhar, Ian James Doxsee, Alex Goldberg, Lars V. Heumann, Zilin Huang, Nathaniel Thomas Kadunce, Shahrokh Kazerani, Willard Lew, Vinh Xuan Ngo, Brian Michael O`Keefe, Trevor James Rainey, Benjamin James Roberts, Bing Shi, Dietrich P. Steinhuebel, Winston C. Tse, Anna Michelle Wagner, Xianghong Wang, Scott Alan Wolckenhauer, Chloe Yuyi Wong, Jennifer R. Zhang
  • Publication number: 20230285387
    Abstract: Provided herein are compositions comprising a dextromethorphan analog according to Formula I or Formula II or a pharmaceutically acceptable salt thereof of either of the foregoing, and a co-agent, e.g., an antidepressant such as a serotonin norepinephrine reuptake inhibitor; a serotonin noradrenaline dopamine reuptake inhibitor; a norepinephrine dopamine reuptake inhibitor; a monoamine oxidase inhibitor; a selective serotonin reuptake inhibitor; and a tricyclic antidepressant or a pharmaceutically acceptable salt of any of the foregoing. The compositions are useful in the treatment of pseudobulbar affect, neuropathic pain, neurodegenerative diseases, brain injuries, and the like.
    Type: Application
    Filed: October 6, 2022
    Publication date: September 14, 2023
    Inventor: Amanda Thomas
  • Publication number: 20220023292
    Abstract: Provided herein are compositions comprising a dextromethorphan analog according to Formula I or Formula II or a pharmaceutically acceptable salt thereof of either of the foregoing, and a co-agent, e.g., an antidepressant such as a serotonin norepinephrine reuptake inhibitor; a serotonin noradrenaline dopamine reuptake inhibitor; a norepinephrine dopamine reuptake inhibitor; a monoamine oxidase inhibitor; a selective serotonin reuptake inhibitor; and a tricyclic antidepressant or a pharmaceutically acceptable salt of any of the foregoing. The compositions are useful in the treatment of pseudobulbar affect, neuropathic pain, neurodegenerative diseases, brain injuries, and the like.
    Type: Application
    Filed: February 22, 2021
    Publication date: January 27, 2022
    Inventor: Amanda Thomas
  • Publication number: 20180344727
    Abstract: Provided herein are compositions comprising a dextromethorphan analog according to Formula I or Formula II or a pharmaceutically acceptable salt thereof of either of the foregoing, and a co-agent, e.g., an antidepressant such as a serotonin norepinephrine reuptake inhibitor; a serotonin noradrenaline dopamine reuptake inhibitor; a norepinephrine dopamine reuptake inhibitor; a monoamine oxidase inhibitor; a selective serotonin reuptake inhibitor; and a tricyclic antidepressant or a pharmaceutically acceptable salt of any of the foregoing. The compositions are useful in the treatment of pseudobulbar affect, neuropathic pain, neurodegenerative diseases, brain injuries, and the like.
    Type: Application
    Filed: December 26, 2017
    Publication date: December 6, 2018
    Applicant: Concert Pharmaceuticals, Inc.
    Inventor: Amanda Thomas
  • Publication number: 20160143902
    Abstract: Provided herein are compositions comprising a dextromethorphan analog according to Formula I or Formula II or a pharmaceutically acceptable salt thereof of either of the foregoing, and a co-agent, e.g., an antidepressant such as a serotonin norepinephrine reuptake inhibitor; a serotonin noradrenaline dopamine reuptake inhibitor; a norepinephrine dopamine reuptake inhibitor; a monoamine oxidase inhibitor; a selective serotonin reuptake inhibitor; and a tricyclic antidepressant or a pharmaceutically acceptable salt of any of the foregoing. The compositions are useful in the the treatment of pseudobulbar affect, neuropathic pain, neurodegenerative diseases, brain injuries, and the like.
    Type: Application
    Filed: November 30, 2015
    Publication date: May 26, 2016
    Inventor: Amanda Thomas
  • Publication number: 20150088700
    Abstract: A system and method of generating recommendations for users to sell items that they have previously purchased are described. An inventory of items of a user may be determined. The inventory of items may comprise items the user has purchased. For each item in the inventory of items, corresponding sale price information and corresponding purchase date information reflecting when the user purchased the corresponding item may be determined. A score may then be determined for each item in the inventory of items based on the corresponding sale price information and the corresponding purchase date information. At least one item from the inventory of items may be determined to recommend for sale by the user based on the corresponding score of the at least one item.
    Type: Application
    Filed: September 20, 2013
    Publication date: March 26, 2015
    Applicant: eBay Inc.
    Inventors: Scot Fraser Hamilton, Steve Cheng, Lien Ekdahl, Amanda Thomas
  • Patent number: 8819224
    Abstract: Methods, systems and computer program products for monitoring and analysis of network servers and web analytics programs are disclosed. A monitoring program, for example, is configured to monitor the status of web analytics program(s) associated with one or more network servers. The monitoring program may monitor server-specific metrics such as server free disk space, server available memory, server on-line/off-line status, report processing time, difference between system time and log file time, table size details, etc. The program may be configured to present status indicators to the user that are indicative of the health of the web analytics program and/or server. A user may receive an alert generated by the monitoring program regarding a change in web analytics program status. Additionally, the monitoring program may be configured to automatically take corrective action to remedy or prevent a critical event that may cause loss of data or delay web analytics reporting.
    Type: Grant
    Filed: July 28, 2011
    Date of Patent: August 26, 2014
    Assignee: Bank of America Corporation
    Inventors: Brian J. Grossklas, John T. Schwartz, Paul Jacob Abernathy, Angelito A. Reyes, Amanda Thomas, Julie Mathew, Jameel Ahmed Jamal, Mathan Kumar
  • Publication number: 20130031238
    Abstract: Methods, systems and computer program products for monitoring and analysis of network servers and web analytics programs are disclosed. A monitoring program, for example, is configured to monitor the status of web analytics program(s) associated with one or more network servers. The monitoring program may monitor server-specific metrics such as server free disk space, server available memory, server on-line/off-line status, report processing time, difference between system time and log file time, table size details, etc. The program may be configured to present status indicators to the user that are indicative of the health of the web analytics program and/or server. A user may receive an alert generated by the monitoring program regarding a change in web analytics program status. Additionally, the monitoring program may be configured to automatically take corrective action to remedy or prevent a critical event that may cause loss of data or delay web analytics reporting.
    Type: Application
    Filed: July 28, 2011
    Publication date: January 31, 2013
    Applicant: Bank of America Corporation
    Inventors: Brian J. Grossklas, John T. Schwartz, Paul Jacob Abernathy, Angelito A. Reyes, Amanda Thomas, Julie Mathew, Jameel Ahmed Jamal, Mathan Kumar
  • Publication number: 20120083487
    Abstract: Provided herein are compositions comprising a dextromethorphan analog according to Formula I or Formula II or a pharmaceutically acceptable salt thereof of either of the foregoing, and a co-agent, e.g., an antidepressant such as a serotonin norepinephrine reuptake inhibitor; a serotonin noradrenaline dopamine reuptake inhibitor; a norepinephrine dopamine reuptake inhibitor; a monoamine oxidase inhibitor; a selective serotonin reuptake inhibitor; and a tricyclic antidepressant or a pharmaceutically acceptable salt of any of the foregoing. The compositions are useful in the treatment of pseudobulbar affect, neuropathic pain, neurodegenerative diseases, brain injuries, and the like.
    Type: Application
    Filed: October 30, 2009
    Publication date: April 5, 2012
    Inventor: Amanda Thomas
  • Publication number: 20120053169
    Abstract: Provided herein are compositions comprising a dextromethorphan analog according to Formula I or Formula II or a pharmaceutically acceptable salt of either of the foregoing and a co-agent, e.g., an antidepressant such as a serotonin norepinephrine reuptake inhibitor; a serotonin noradrenaline dopamine reuptake inhibitor; a norepinephrine dopamine reuptake inhibitor; a monoamine oxidase inhibitor; a selective serotonin reuptake inhibitor; and a tricyclic antidepressant or a pharmaceutically acceptable salt of any of the foregoing. The compositions are useful in the treatment of pseudobulbar affect, neuropathic pain, neurodegenerative diseases, brain injuries, and the like.
    Type: Application
    Filed: October 30, 2009
    Publication date: March 1, 2012
    Inventor: Amanda Thomas